期刊文献+

急性冠脉综合征患者血浆中NT-proBNP和hs-CRP联合检测的应用价值 被引量:2

Combined detection of plasma levels of N-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein for patients with acute coronary syndrome:an investigation of its clinical value
下载PDF
导出
摘要 目的检测急性冠脉综合征(ACS)患者血浆中氨基末端钠尿肽前体(NT-proBNP)和超敏CRP(hs-CRP)含量水平,以探讨其在ACS诊断及预后评估中的应用价值。方法将126例ACS患者作为观察组,58例健康体检者作为对照组;用放射免疫分析法和vitros ECi免疫发光法同时检测2组样本血浆中的hs-CRP和NT-proBNP含量水平,并采用t检验比较2组的x珋±s差异有无显著性,对NT-proBNP与hs-CRP水平关系运用Pearson相关性分析。结果ACS患者组血浆中的NT-proBNP和hs-CRP含量水平均显著高于对照组(P<0.01),对NT-proBNP与hs-CRP浓度水平关系运用Pearson相关性分析,结果表明二者呈显著正相关(P<0.05)。结论联合检测血浆中的NT-proBNP和hs-CRP含量水平,对ACS的诊断和预后评估具有较重要的价值。 Objective To investigate the levels of N-Terminal proB-Type natriuretic peptide ( NT-proBNP) and high-sen-sitivity C-reactive protein (hs-CRP) in plasma of patients with acute coronary syndrome (ACS),and to explore the clinical meanings.Methods 126 ACS patients were set as an observation group ,and 58 healthy adults as a control group .Radiation immunity analysis method and vitros ECi immune luminescence detection were applied simultaneously to detect the hs -CRP and the NT-proBNP levels in plasma of two sets of samples;x±s of the two groups were calculated respectively by using t test to compare differences .Pearson correlation analysis was conducted to analyze the relationship between the NT -proBNP and hs-CRP levels.Results In comparison with the normal controls ,the levels of NT-proBNP and hs-CRP were higher in ACS pa-tients.The difference was significant(P〈0.01).The level of NT-proBNP was positively correlated with that of hs-CRP(P〈0.05).Conclusion Combined detection of plasma levels of NT-proBNP and hs-CRP is of clinical value for the diagnosis and prognosis of ACS .
出处 《淮海医药》 CAS 2014年第4期323-325,共3页 Journal of Huaihai Medicine
关键词 急性冠脉综合征 氨基末端脑钠肽前体 超敏CRP Acute coronary syndrome N-Terminal proB-type natriuretic peptide High sensitive C-reactive protein
  • 相关文献

参考文献10

  • 1Seino Y, Ogawa A, Yamashita T, et al. Application of NT-proBNP and BNP measurements in cardiac care : a more discerning marker for the detection and evaluation of heart failure [ J 1. Eur J Heart Fail, 2004,6(3 ) :295-300.
  • 2Gravning J, Smedsrud MK, Omland T, et al. Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syn- drome : prediction of significant coronary lesions and long-term prog- nosis[ J]. Am Heart J ,2013,165 ( 5 ) :716-724.
  • 3Holm J, Vidlund M, Vanky F, eta/. Preoperative NT-pmBNP inde- pendently predicts outcome in patients with acute coronary syndrome undergoing CABG[J]. Stand Cardiovasc J Suppl,2013,47 (1) :28- 35.
  • 4Leistner DM, Klotsche J, Pieper L, et ai. Prognostic value of NT-pro- BNP and hs-CRP for risk stratification in primary care:results from the population-based DETECT study [ J]. Clin Res Cardiol, 2013, 102(4) :259-268.
  • 5Musani SK, Vasan RS, Bidulescu A, et 81. Aldosterone, C-reactive protein, and plasma B-type natriuretic peptide are associated with the development of metabolic syndrome and longitudinal changes in met- abolic syndrome components:findings from the Jackson Heart Study [ J]. Diabetes Care,2013,36(10) :3084-3092.
  • 6van der Zee PM, Cornel JH, Bholasingh R, et al. N-terminal pro B- type natriuretie peptide identifies patients with chest pain at high long-term cardiovascular risk [ J ]. Am J Med, 2011,124 ( 10 ) : 961- 969.
  • 7Jaberg L, Toggweiler S, Puck M, et al. Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syn- dromes undergoing left main percutaneous coronary intervention [ J ]. Circ J ,2011,75 ( 11 ) :2648-2653.
  • 8Beleigoli AM, Boersma E, Diniz Mde F, et al. C-reactive protein and B-type natriuretic peptide yield either a non-significant or a modest incremental value to traditional risk factors in predicting long-term o- verall mortality in older adults [ J ]. PLoS One, 2013,25 ; 8 ( 9 ) : e75809.
  • 9Eggers KM, Kempf T, Venge P, et al. Improving long-term risk pre- diction in patients with acute chest pain:the Global Registry of A- cute Coronary Events (GRACE) risk score is enhanced by selected nonnecrosis biomarkers[ J]. Am Heart J ,2010,160( 1 ) :88-94.
  • 10Leistner DM, Klotsche J, Pieper L, et al. Prognostic value of NT-pro- BNP and hs-CRP for risk stratification in primary care:results from the population-based DETECT study[ J]. Clin Res Cardiol,2013 , 102 (4) :259-268.

同被引文献11

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部